Combination of MRI-based prediction and CRISPR/Cas12a-based detection for IDH genotyping in glioma.
Ontology highlight
ABSTRACT: Early identification of IDH mutation status is of great significance in clinical therapeutic decision-making in the treatment of glioma. We demonstrate a technological solution to improve the accuracy and reliability of IDH mutation detection by combining MRI-based prediction and a CRISPR-based automatic integrated gene detection system (AIGS). A model was constructed to predict the IDH mutation status using whole slices in MRI scans with a Transformer neural network, and the predictive model achieved accuracies of 0.93, 0.87, and 0.84 using the internal and two external test sets, respectively. Additionally, CRISPR/Cas12a-based AIGS was constructed, and AIGS achieved 100% diagnostic accuracy in terms of IDH detection using both frozen tissue and FFPE samples in one hour. Moreover, the fea
SUBMITTER: Yu D
PROVIDER: S-EPMC11217299 | biostudies-literature | 2024 Jul
REPOSITORIES: biostudies-literature
ACCESS DATA